Experienced in Opioid Use Disorder

Dan I. Lubman

Turning Point, 
Richmond, NSW, AU 
Experienced in Opioid Use Disorder
Turning Point, 
Richmond, NSW, AU 
OverviewLocationsClinical Research

Overview

Dan Lubman practices in Richmond, Australia. Mr. Lubman is rated as an Experienced expert by MediFind in the treatment of Opioid Use Disorder. His top areas of expertise are Delirium Tremens, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Opioid Use Disorder.

His clinical research consists of co-authoring 392 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Opioid Use Disorder.

Gender
Male

Locations

Turning Point, Richmond, NSW, Australia
Other Locations
Turning Point, Box Hill, VIC, Australia
900 Dandenong Road, Caulfield East, VIC 3145, Australia
Turning Point, Melbourne, VIC, Australia
Turning Point, Richmond, VIC 3121, Australia
Level 2, 553 St Kilda Road, Melbourne, VIC 3004, Australia
5 Arnold St, Box Hill, VIC 3128, Australia
Turning Point, Clayton, QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Brief Intervention to Increase Knowledge of Alcohol as a Breast Cancer Risk Factor Among Women Attending Breast Screening Services (Health4Her): A Pilot Randomised Controlled Trial
A Brief Intervention to Increase Knowledge of Alcohol as a Breast Cancer Risk Factor Among Women Attending Breast Screening Services (Health4Her): A Pilot Randomised Controlled Trial
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable

392 Total Publications

Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings.
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings.
Journal: BMJ open
Published: November 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lubman's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile